| Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer DY Oh, A Ruth He, S Qin, LT Chen, T Okusaka, A Vogel, JW Kim, ... NEJM evidence 1 (8), EVIDoa2200015, 2022 | 470 | 2022 |
| Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation C Lee, S Jeong, C Jang, H Bae, YH Kim, I Park, SK Kim, GY Koh Science 363 (6427), 644-649, 2019 | 305 | 2019 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 278 | 2023 |
| Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction SJ Lee, C Lee, S Kang, I Park, YH Kim, SK Kim, SP Hong, H Bae, Y He, ... The Journal of clinical investigation 128 (11), 5018-5033, 2018 | 147 | 2018 |
| Impaired angiopoietin/Tie2 signaling compromises Schlemm’s canal integrity and induces glaucoma J Kim, DY Park, H Bae, D Kim, C Lee, S Song, TY Chung, DH Lim, ... The Journal of clinical investigation 127 (10), 3877-3896, 2017 | 93 | 2017 |
| A MST1–FOXO1 cascade establishes endothelial tip cell polarity and facilitates sprouting angiogenesis YH Kim, J Choi, MJ Yang, SP Hong, C Lee, Y Kubota, DS Lim, GY Koh Nature Communications 10 (1), 838, 2019 | 89 | 2019 |
| Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy C Lee, M Jung, I Jung, SJ Heo, YH Jeong, JY An, HI Kim, JH Cheong, ... Annals of surgery 263 (1), 96-102, 2016 | 72 | 2016 |
| Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs C Lee, S Kim, JS Lee, JE Lee, S Kim, IS Yang, HR Kim, JH Lee, S Kim, ... Lung Cancer 113, 106-114, 2017 | 56 | 2017 |
| Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group … C Lee, HJ Chon, J Cheon, MA Lee, HS Im, JS Jang, MH Kim, S Park, ... The Lancet Gastroenterology & Hepatology 8 (1), 56-65, 2023 | 52 | 2023 |
| Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1/programmed death‐ligand 1 blockade responses JG Yoon, MH Kim, MI Jang, H Kim, HK Hwang, CM Kang, WJ Lee, B Kang, ... Hepatology 74 (4), 1914-1931, 2021 | 49 | 2021 |
| PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer C Kim, CK Lee, HJ Chon, JH Kim, HS Park, SJ Heo, HJ Kim, TS Kim, ... Oncotarget 8 (69), 113494, 2017 | 46 | 2017 |
| YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells SY Choi, H Bae, SH Jeong, I Park, H Cho, SP Hong, DH Lee, C Lee, ... Nature Communications 11 (1), 519, 2020 | 43 | 2020 |
| Targeting HER2 in combination with anti-PD-1 and chemotherapy confers a significant tumor shrinkage of gastric cancer: a multi-institutional phase Ib/II trial of first-line … SY Rha, CK Lee, HS Kim, B Kang, M Jung, WK Bae, DH Koo, SJ Shin, ... Journal of Clinical Oncology 38 (15_suppl), 3081-3081, 2020 | 40 | 2020 |
| The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status JS Park, N Lee, SH Beom, HS Kim, C Lee, SY Rha, HC Chung, M Yun, ... Gastric Cancer 21, 213-224, 2018 | 40 | 2018 |
| Angiopoietin-2–integrin α5β1 signaling enhances vascular fatty acid transport and prevents ectopic lipid-induced insulin resistance H Bae, KY Hong, C Lee, C Jang, SJ Lee, K Choe, S Offermanns, Y He, ... Nature communications 11 (1), 2980, 2020 | 37 | 2020 |
| A multi-institutional phase Ib/II trial of first-line triplet regimen (Pembrolizumab, Trastuzumab, Chemotherapy) for HER2-positive advanced gastric and gastroesophageal … SY Rha, C Lee, HS Kim, B Kang, M Jung, WS Kwon, WK Bae, DH Koo, ... Journal of Clinical Oncology 39 (3_suppl), 218-218, 2021 | 36 | 2021 |
| A new practical desensitization protocol for oxaliplatin-induced immediate hypersensitivity reactions: a necessary and useful approach HJ Park, JH Lee, SR Kim, SH Kim, KH Park, CK Lee, BD Kang, SH Beom, ... Esmon Publicidad 26 (3), 168-176, 2016 | 35 | 2016 |
| Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer HS Park, WS Kwon, S Park, E Jo, SJ Lim, C Lee, JB Lee, M Jung, HS Kim, ... Journal for immunotherapy of cancer 7, 1-12, 2019 | 29 | 2019 |
| Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer CK Lee, ME Lee, WS Lee, JM Kim, KH Park, TS Kim, KY Lee, JB Ahn, ... American journal of cancer research 5 (1), 72, 2015 | 29 | 2015 |
| Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective … HS Park, B Kang, HJ Chon, HS Im, CK Lee, I Kim, MJ Kang, JE Hwang, ... ESMO open 6 (2), 100049, 2021 | 26 | 2021 |
